The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Biomarker modulation in patients treated with TRC105 in combination with anti-VEGF therapy.
 
Yingmiao Liu
No Relationships to Disclose
 
Zhenhua Yuan
No Relationships to Disclose
 
Dadong Zhang
No Relationships to Disclose
 
Mark D. Starr
No Relationships to Disclose
 
John C. Brady
No Relationships to Disclose
 
Manoj A. Jivani
Employment - TRACON Pharma
Stock and Other Ownership Interests - TRACON Pharma
 
Bonne J. Adams
Employment - TRACON Pharma
Stock and Other Ownership Interests - TRACON Pharma
Patents, Royalties, Other Intellectual Property - TRACON Pharma
 
Delia Alvarez
Employment - Tricon Pharmaceuticals
Stock and Other Ownership Interests - TRACON Pharma
 
Steven Attia
Consulting or Advisory Role - EMD Serono; Karyopharm Therapeutics
Research Funding - AB Science (Inst); Bayer (Inst); Bayer (Inst); CytRx Corporation (Inst); Daiichi Sankyo (Inst); Epizyme (Inst); Immune Design (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Lilly (Inst); Morphotek (Inst); Novartis (Inst); Novartis (Inst); Threshold Pharmaceuticals (Inst); TRACON Pharma (Inst); ZIOPHARM Oncology (Inst)
 
Toni K. Choueiri
Honoraria - NCCN; UpToDate
Consulting or Advisory Role - alligent; AstraZeneca; Bayer; Bristol-Myers Squibb; Cerulean Pharma; Eisai; Exelixis; Foundation Medicine; GlaxoSmithKline; Merck; Novartis; Peloton Therapeutics; Pfizer; Prometheus; Roche/Genentech
Research Funding - Agensys (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); TRACON Pharma (Inst)
Travel, Accommodations, Expenses - advisory boards/consultancy
 
Charles P. Theuer
Employment - TRACON Pharma
Leadership - TRACON Pharma
Stock and Other Ownership Interests - TRACON Pharma
Patents, Royalties, Other Intellectual Property - TRACON Pharma
 
Kouros Owzar
Patents, Royalties, Other Intellectual Property - Duke University (Inst)
 
Herbert Hurwitz
Honoraria - Genentech/Roche; Lilly/ImClone
Consulting or Advisory Role - Acceleron Pharma; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Incyte; Lilly; Novartis; OncoMed; TRACON Pharma
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Macrogenics (Inst); NCI (Inst); Novartis (Inst); Regeneron (Inst); TRACON Pharma (Inst)
 
Andrew B. Nixon
Consulting or Advisory Role - Cerulean Pharma; Novartis; Pfizer
Research Funding - Acceleron Pharma; Amgen; Genentech/Roche; Incyte; medpacto; Novartis; Seagen; TRACON Pharma
Patents, Royalties, Other Intellectual Property - Patent Pending (Inst); Patent pending (Inst)